Saturday, September 26, 2020

Tag: diabetes

Stocks to be in before 2021

Glucose Health, Inc. is an under-the-radar company whose GLUCODOWN® products are found in major national pharmacy chains including Walmart (NYSE: WMT), CVS Health (NYSE: CVS) and even online at Amazon.com (NASDAQ: AMZN) yet is still trading below a $20 million valuation.

Glucose Health, Inc. (GLUC) Unveils GLUCODOWN® “Enhanced Water” Drink Mix Retail...

Glucose Health, Inc. (GLUC) Unveils GLUCODOWN® "Enhanced Water" Drink Mix Retail Packaging and 2020 Launch Date

The Stocks to own after the Presidential Election

Joe Biden wants to put the U.S. on track to achieve "a 100% clean energy economy and Brookfield Renewable Partners (NYSE:BEP) stands out as one stock positioned to perform especially well as three-quarters of the company's funds from operations (FFO) comes from its hydroelectric facilities.

Stocks to Own for a Pandemic Recovery

Take a look at Glucose Health, Inc. (OTC Pink: GLUC). Trading with less than a $20 million valuation, Glucose Health manufacturers nutritional beverages for the diabetic-adult nutrition consumer retail category under the registered trademark GLUCODOWN®.

The Best Healthcare Stocks for 2020

The Best Healthcare Stocks for 2020. Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 sales. 2nd quarter fiscal 2020 revenues increased 186% compared to the 2nd quarter of fiscal 2019 – Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.

The Sectors to be invested in for the remainder of 2020

On the healthcare front, Edesa Biotech (NASDAQ: EDSA) has an interesting chart. Between $8 and 9.00 per share sits a major pivot created on August 11, 2020. If the stock can maintain above it, the ceiling will become the floor and the stock will have room to $19.00 per share.

Medical Marijuana Stocks and Ailments they Treat

Web MD recently released an article discussing what medical marijuana is used for.  It notes ailments such as:

Recession Proof Stocks to Own Right Now

Over the past 12 months, GLUC has seen a range of approximately $.20 - $1.90 per share and with only 12.5 million shares outstanding, GLUC could be the best value in the diabetes space and should be on everybody’s watch list.

The One Factor That May Distinguish Can-Fite BioPharma (CANF)

This is a play on the treatment of Covid-19 rather than a preventative vaccine Before the pandemic, one of the flagship drugs under the Can-Fite pipeline was Piclidenoson. An orally administered drug, Piclidenoson is essentially a small-molecule inhibitor that targets enzymes that cause inflammation.

Glucose Health (GLUC) Expanded Inventory to Meet Consumer Demand Plus all...

Glucose Health (GLUC) Expanded Inventory to Meet Consumer Demand Plus all New GLUCODOWN® "Enhanced Water" Beverages From Glucose Health, Inc.